Pfizer Inc. (NYSE:PFE) is one of the Most Undervalued Long Term Stocks to Buy Right Now. On October 19, Pfizer Inc. (NYSE:PFE ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

This sustained sell-off has wiped out approximately $18 billion in market capitalization, leaving its current value at around ...

Earnings season hits full stride in the last week of October, with a broad cross-sector lineup spanning tech, energy, ...

Pfizer Inc. is a global biopharmaceutical leader with a diversified product portfolio and significant scale, supported by ...

Pfizer (PFE) offers potential 20-30% upside despite revenue risks. Explore its valuation, pipeline prospects, and dividend ...

Pfizer (PFE) shares have been inching upward recently, sparking some fresh attention from investors looking to understand ...

Pfizer enters the obesity drug market with a reasonably valued deal, while valuation remains attractive and technicals show ...

In a report released on October 10, Courtney Breen from Bernstein maintained a Hold rating on Pfizer, with a price target of $30.00. The company’s shares closed last Friday at $24.78. Take advantage ...

Baby Boomers should be looking to play things a bit more cautiously as stock valuations begin to climb across the board.

Investors in Pfizer Inc (Symbol: PFE) saw new options begin trading today, for the February 2024 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is ...